Matches in SemOpenAlex for { <https://semopenalex.org/work/W2283460279> ?p ?o ?g. }
- W2283460279 endingPage "1559" @default.
- W2283460279 startingPage "1553" @default.
- W2283460279 abstract "IntroductionEpidermal growth factor receptor (EGFR) mutation T790M accounts for approximately half of acquired resistances to EGFR-tyrosine kinase inhibitor (TKI). Because T790M is mediated by TKI exposure, its penetration and “on–off” may affect T790M status.MethodsWe retrospectively reviewed T790M status and clinical course of patients who had undergone multiple rebiopsies after acquired resistance to EGFR-TKI.ResultsOf 145 patients with EGFR-mutant NSCLC receiving rebiopsy after acquired resistance, 30 underwent multiple site rebiopsies, and 24 received repeated rebiopsies at the same lesion. In 22 patients who underwent rebiopsies from both central nervous system (CNS; 20 cerebrospinal fluids [CSF] and 2 brain tumoral tissues) and thoracic lesions (7 lung tissues, 14 pleural effusions, and 1 lymph node), 12 were thoracic-T790M-positive. Of these 12 patients, 10 were CNS-T790M-negative, despite exhibiting thoracic-T790M-positive. All 10 thoracic-T790M-negatives were CNS-T790M-negative. Three patients revealed a spatial heterogeneous T790M status among their thoracic lesions. In 24 patients receiving repeated rebiopsies at the same lesion (12 lung tissues, 6 CSFs, and 6 pleural effusions), T790M status of lung lesions varied in five patients after TKI-free interval. In all five patients whose T790M status changed from positive to negative, EGFR-TKI rechallenge was effective. In three of these five patients, after further TKI exposure, T790M status changed from negative to positive again. There was also a patient whose CSF T790M status changed from negative to positive after high-dose erlotinib therapy.ConclusionsT790M status in an individual patient can be spatiotemporally heterogeneous because of selective pressure from EGFR-TKI. Epidermal growth factor receptor (EGFR) mutation T790M accounts for approximately half of acquired resistances to EGFR-tyrosine kinase inhibitor (TKI). Because T790M is mediated by TKI exposure, its penetration and “on–off” may affect T790M status. We retrospectively reviewed T790M status and clinical course of patients who had undergone multiple rebiopsies after acquired resistance to EGFR-TKI. Of 145 patients with EGFR-mutant NSCLC receiving rebiopsy after acquired resistance, 30 underwent multiple site rebiopsies, and 24 received repeated rebiopsies at the same lesion. In 22 patients who underwent rebiopsies from both central nervous system (CNS; 20 cerebrospinal fluids [CSF] and 2 brain tumoral tissues) and thoracic lesions (7 lung tissues, 14 pleural effusions, and 1 lymph node), 12 were thoracic-T790M-positive. Of these 12 patients, 10 were CNS-T790M-negative, despite exhibiting thoracic-T790M-positive. All 10 thoracic-T790M-negatives were CNS-T790M-negative. Three patients revealed a spatial heterogeneous T790M status among their thoracic lesions. In 24 patients receiving repeated rebiopsies at the same lesion (12 lung tissues, 6 CSFs, and 6 pleural effusions), T790M status of lung lesions varied in five patients after TKI-free interval. In all five patients whose T790M status changed from positive to negative, EGFR-TKI rechallenge was effective. In three of these five patients, after further TKI exposure, T790M status changed from negative to positive again. There was also a patient whose CSF T790M status changed from negative to positive after high-dose erlotinib therapy. T790M status in an individual patient can be spatiotemporally heterogeneous because of selective pressure from EGFR-TKI." @default.
- W2283460279 created "2016-06-24" @default.
- W2283460279 creator A5000653374 @default.
- W2283460279 creator A5011349417 @default.
- W2283460279 creator A5016131935 @default.
- W2283460279 creator A5022022857 @default.
- W2283460279 creator A5034733511 @default.
- W2283460279 creator A5041182728 @default.
- W2283460279 creator A5044441003 @default.
- W2283460279 creator A5065196329 @default.
- W2283460279 creator A5072676622 @default.
- W2283460279 creator A5080938148 @default.
- W2283460279 creator A5091096026 @default.
- W2283460279 date "2015-11-01" @default.
- W2283460279 modified "2023-10-13" @default.
- W2283460279 title "Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI" @default.
- W2283460279 cites W1502361999 @default.
- W2283460279 cites W1607191560 @default.
- W2283460279 cites W1973554995 @default.
- W2283460279 cites W1979332174 @default.
- W2283460279 cites W1980497534 @default.
- W2283460279 cites W1998971866 @default.
- W2283460279 cites W2002937040 @default.
- W2283460279 cites W2003984225 @default.
- W2283460279 cites W2032691545 @default.
- W2283460279 cites W2043696829 @default.
- W2283460279 cites W2055402151 @default.
- W2283460279 cites W2063790560 @default.
- W2283460279 cites W2073065368 @default.
- W2283460279 cites W2091083398 @default.
- W2283460279 cites W2096198395 @default.
- W2283460279 cites W2098395191 @default.
- W2283460279 cites W2111662961 @default.
- W2283460279 cites W2112602910 @default.
- W2283460279 cites W2119351872 @default.
- W2283460279 cites W2126767708 @default.
- W2283460279 cites W2128385295 @default.
- W2283460279 cites W2128688922 @default.
- W2283460279 cites W2129360604 @default.
- W2283460279 cites W2131036723 @default.
- W2283460279 cites W2132157071 @default.
- W2283460279 cites W2136263263 @default.
- W2283460279 cites W2138089710 @default.
- W2283460279 cites W2139799027 @default.
- W2283460279 cites W2145980885 @default.
- W2283460279 cites W2156560090 @default.
- W2283460279 cites W2159013299 @default.
- W2283460279 cites W2160040938 @default.
- W2283460279 cites W2160982674 @default.
- W2283460279 cites W2161821474 @default.
- W2283460279 cites W2166084034 @default.
- W2283460279 cites W2167948710 @default.
- W2283460279 cites W2171139285 @default.
- W2283460279 cites W2461360472 @default.
- W2283460279 cites W2605292800 @default.
- W2283460279 cites W3012119175 @default.
- W2283460279 doi "https://doi.org/10.1097/jto.0000000000000647" @default.
- W2283460279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26309190" @default.
- W2283460279 hasPublicationYear "2015" @default.
- W2283460279 type Work @default.
- W2283460279 sameAs 2283460279 @default.
- W2283460279 citedByCount "128" @default.
- W2283460279 countsByYear W22834602792015 @default.
- W2283460279 countsByYear W22834602792016 @default.
- W2283460279 countsByYear W22834602792017 @default.
- W2283460279 countsByYear W22834602792018 @default.
- W2283460279 countsByYear W22834602792019 @default.
- W2283460279 countsByYear W22834602792020 @default.
- W2283460279 countsByYear W22834602792021 @default.
- W2283460279 countsByYear W22834602792022 @default.
- W2283460279 countsByYear W22834602792023 @default.
- W2283460279 crossrefType "journal-article" @default.
- W2283460279 hasAuthorship W2283460279A5000653374 @default.
- W2283460279 hasAuthorship W2283460279A5011349417 @default.
- W2283460279 hasAuthorship W2283460279A5016131935 @default.
- W2283460279 hasAuthorship W2283460279A5022022857 @default.
- W2283460279 hasAuthorship W2283460279A5034733511 @default.
- W2283460279 hasAuthorship W2283460279A5041182728 @default.
- W2283460279 hasAuthorship W2283460279A5044441003 @default.
- W2283460279 hasAuthorship W2283460279A5065196329 @default.
- W2283460279 hasAuthorship W2283460279A5072676622 @default.
- W2283460279 hasAuthorship W2283460279A5080938148 @default.
- W2283460279 hasAuthorship W2283460279A5091096026 @default.
- W2283460279 hasBestOaLocation W22834602791 @default.
- W2283460279 hasConcept C121608353 @default.
- W2283460279 hasConcept C126322002 @default.
- W2283460279 hasConcept C142724271 @default.
- W2283460279 hasConcept C143998085 @default.
- W2283460279 hasConcept C2776256026 @default.
- W2283460279 hasConcept C2777714996 @default.
- W2283460279 hasConcept C2777930144 @default.
- W2283460279 hasConcept C2779438470 @default.
- W2283460279 hasConcept C2780580887 @default.
- W2283460279 hasConcept C2780849966 @default.
- W2283460279 hasConcept C71924100 @default.
- W2283460279 hasConceptScore W2283460279C121608353 @default.
- W2283460279 hasConceptScore W2283460279C126322002 @default.
- W2283460279 hasConceptScore W2283460279C142724271 @default.